NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $967,000 | -17.4% | 11,665 | -25.2% | 0.25% | -10.2% |
| Q4 2021 | $1,171,000 | -37.7% | 15,590 | -3.6% | 0.28% | -44.2% |
| Q3 2021 | $1,880,000 | -47.6% | 16,180 | 0.0% | 0.49% | -47.8% |
| Q2 2021 | $3,589,000 | +69.0% | 16,180 | +0.7% | 0.94% | +56.3% |
| Q1 2021 | $2,124,000 | -27.3% | 16,070 | -4.9% | 0.60% | -27.3% |
| Q4 2020 | $2,923,000 | +53.5% | 16,895 | -1.2% | 0.83% | +36.7% |
| Q3 2020 | $1,904,000 | +88.5% | 17,105 | +0.4% | 0.61% | +68.0% |
| Q2 2020 | $1,010,000 | – | 17,030 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |